Market Access News | pharmaphorum

News

Keeping up the PACE at the Scottish Medicines Consortium

After a nay from NICE, Scotland says aye to J&J’s Spravato

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug that has been turned down twice by NICE for patients in England.

News

COVID-19 vaccine could be ready in time for US elections

Health officials in the US have been told to prepare for a COVID-19 vaccine to be ready by November ahead of the US presidential elections, according to press reports.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Canada signs deals for J&J, Novavax COVID vaccines

The Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates.

News

NICE rejects Janssen's depression spray Spravato for second ...

NICE has rejected regular NHS funding for Janssen’s depression spray Spravato (esketamine) for a second time, although the company says it could salvage the situation by providing further d

News

Novo launches type 2 diabetes pill in UK after NICE waives r...

Novo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost-effectiveness watchdog NICE decided that there was no need to review it.

News